Vietnam Nanomedicine Market Size, Share, By Type (Nanoparticles, Nanoshells, Nanotubes, And Nanodevices), By Product (Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, And Vaccines), By Application (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, And Others), And Vietnam Nanomedicine Market Insights, Industry Trend, Forecasts to 2035

Vietnam Nanomedicine Market Insights Forecasts to 2035

• Vietnam Nanomedicine Market Size 2024: USD 1.05 Bn
• Vietnam Nanomedicine Market Size 2035:  USD 3.8 Bn
• Vietnam Nanomedicine Market CAGR 2024: 12.4%
• Vietnam Nanomedicine Market Segments: Type, Product, and Application

The Vietnam Nanomedicine Market Size encompasses the use of nanotechnology in medicine. Nanotechnology is the application of nanomaterial properties to develop new technologies for healthcare. These technologies include targeted drug delivery systems, improved diagnostics, treatment methods, and drug formulations. Nanomedicine is an intersection of physics, materials science, biology and engineering to create nano-carriers that provide targeted delivery of medications, reduce the likelihood of adverse effects, and improve patient outcomes within the areas of medical oncology; infectious diseases; cardiovascular health; regenerative medicine; and vaccines by employing unique physical, chemical, and biological properties present in nanomaterial that are not found in conventional bulk substances.

The Nanomedicine in Vietnam are backed by government support, including the Vietnam's first manufacturing line in the field of biological nanotechnology was launched in partnership with the Vietnam Academy of Science and Technology by Cam Ha JSC. Vietnam is expected to invest approximately VND 95 trillion from the national budget towards the development of technology, innovation, digital transformation and the development of nanomedicine as well as to establish new infrastructure for research into this area by the year 2026. In addition, national policies will require that application of science and technology provides 5% or more of GDP growth.

As technology advances, Vietnam nanomedicine providers are now using nanoparticle-based delivery vehicles that enable more soluble, bioavailable, and directed delivery of molecules, while also increasing the possibility for improved detection of diseases through developing new diagnostic tools based on devices combined with nanotechnology. Advancements in Nanomedicine have become part of a larger cycle of co-operation and development within the scientific community, with contributions from numerous biomedical companies around the world working closely with collaborative projects between universities and researchers in Vietnam, to accelerate innovation within the field of Nano Technologies.

Market Dynamics of the Vietnam Nanomedicine Market:

The Vietnam nanomedicine market is driven by the increased demand for healthcare due, more individuals undergoing treatments for chronic illnesses, increased investment by organizations in nanomedicine, rise in awareness by health care providers and patients and increased collaborative R&D on nanomedicines regionally.

The Vietnam nanomedicine market is restrained by the high development and production costs, complex regulatory and approval pathways, shortage of highly specialized talent in nanotechnology and biotechnology, and limited local manufacturing infrastructure.

The future of Vietnam nanomedicine market is bright and promising, with versatile opportunities emerging from the increasing demand for personalized and targeted therapy using nano-enabled platforms; the expansion of research and innovation through public-private partnerships; favourable government policies to attract experts and encourage research and development and collaborations across different industries to deliver nanomedicine solutions to a wider range of healthcare and biotechnology ecosystems. In addition, combining nanotechnology with next-generation digital health and artificial intelligence platforms create opportunities to develop new diagnostic and therapeutic products for difficult to treat diseases and establish Vietnam as a new player in the global nanomedicine arena.

Market Segmentation

The Vietnam Nanomedicine Market share is classified into type, product, and application.

By Type:

The Vietnam nanomedicine market is divided by type into nanoparticles, nanoshells, nanotubes, and nanodevices. Among these, the nanoparticles segment held the largest revenue market share in 2024 and is predicted to grow at a remarkable CAGR during the forecast period. Unmatched versatility for drug delivery improving solubility, targeting cancer, diagnostics, and tissue engineering, offering enhanced efficacy, fewer side effects, and cost effective type all contribute to the nanoparticles segment's largest share and higher spending on nanomedicine when compared to other type.

By Product:

The Vietnam nanomedicine market is divided by product into therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines. Among these, the therapeutics segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The therapeutics segment dominates because of it encompasses a vast range of products and delivery systems targeting major diseases, offering better efficacy, fewer side effects and addressing unmet needs with rising chronic diseases.

By Application:

The Vietnam nanomedicine market is divided by application into clinical oncology, infectious diseases, clinical cardiology, orthopaedics, and others. Among these, the clinical oncology segment held the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Rise in incidence of cancer in the country, nanomedicines ability to provide more effective, targeted therapies with fewer side effects compared to conventional treatments all contribute to the clinical oncology segment's largest share and higher spending on nanomedicine when compared to other application.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Vietnam nanomedicine market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Key Companies in Vietnam Nanomedicine Market:

• Nanogen Pharmaceutical Biotechnology
• Innocare Pharmaceuticals Co., Ltd.
• N2TP Technology Solutions JSC
• METAMED
• Vietnam Academy of Science and Technology
• Hanoi University of Science and Technology & Institute of Materials Science
• Abbott Laboratories
• Merck & Co., Inc.
• Pfizer, Inc.
• Johnson & Johnson Services, Inc.
• GE HealthCare
• Others

Recent Developments in Vietnam Nanomedicine Market:

In September 2025, VNVC signed a collaboration and technology transfer deal with Russia’s Medsintez to boost production capabilities of advanced biologics and partners on R&D that supports nano-scale biologic platforms.

In May 2025, Biochempha shared collaboration and strategic transfer of nano tech with partners to advance Nanomedicine applications in Vietnam.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Vietnam, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the Vietnam nanomedicine market based on the below-mentioned segments:

Vietnam Nanomedicine Market, By Type

• Nanoparticles
• Nanoshells
• Nanotubes
• Nanodevices

Vietnam Nanomedicine Market, By Product

• Therapeutics
• Regenerative Medicine
• In-Vitro Diagnostics
• In-Vivo Diagn
• ostics
• Vaccines

Vietnam Nanomedicine Market, By Application

• Clinical Oncology
• Infectious Diseases
• Clinical Cardiology
• Orthopedics
• Others